factual

What was the net income for Learningrx in 2023?

Learningrx Franchise · 2025 FDD

Answer from 2025 FDD Document

n ended in accordance with accounting principles generally | | | | | | accepted in the United States of America. | | | | |

LearningRx Franchise Corporation Statements of Income For the Years Ended September 30, 2024 and 2023

2024 2023
Income
Royalty fees $ 1,192,359 $ 1,192,063
Initial franchise fees 114,551 162,286
Area development fees 9,769 6,200
Technology and training fees 113,401 112,854
Transfer fees 24,500 -
Renewal fees 7,000 7,000
Materials fees 15,888 16,479
Marketing fees 73,535 17,418
Interest and other income 20,726 5,295
Total Income 1,571,729 1,519,595
Expenses
Bad debt 29,764 -
Depreciation 898 898
Franchise system expenses 615,225 564,949
Marketing and development 50,212 34,373
Outside consultants 104,033 105,341
Overhead 79,864 133,279
Professional fees 67,938 90,734
Rent 60,000 80,000
Research and development 24,000

Source: Item 23 — RECEIPT (FDD pages 54–209)

What This Means (2025 FDD)

According to Learningrx's 2025 Franchise Disclosure Document, the net income for Learningrx in 2023 was $7,181. This figure represents the company's profit after all expenses, including income taxes, have been deducted from its total income for the fiscal year. The document provides a comparative view, showing the net income alongside other financial metrics for both 2024 and 2023. This allows prospective franchisees to assess the financial performance and stability of Learningrx over these two years.

Specifically, the FDD reveals that Learningrx's total income in 2023 was $1,519,595, while total expenses amounted to $1,500,933. After subtracting expenses from income, the net income before income taxes was $18,662. However, after accounting for income tax expenses of $11,481, the final net income was $7,181.

It's important for potential franchisees to consider this net income figure in the context of Learningrx's overall financial health and trends. While the net income for 2023 was positive, it was significantly lower than the $169,308 net income reported for 2024. This difference could be due to various factors, such as changes in revenue, increased expenses, or fluctuations in tax liabilities. A thorough review of the complete financial statements and discussions with Learningrx's management team are advisable to understand the underlying reasons for these changes and to assess the potential financial risks and opportunities associated with investing in a Learningrx franchise.

Disclaimer: This information is extracted from the 2025 Franchise Disclosure Document and is provided for research purposes only. It does not constitute legal or financial advice. Consult with a franchise attorney before making any investment decisions.